Yarrow Bioscience (YARW) Current Leases (2019 - 2025)

Yarrow Bioscience (YARW) has reported Current Leases for 7 consecutive years, with $25000.0 the latest figure, recorded in Q2 2025.

• For the quarter ending Q2 2025, Current Leases fell 79.17% year-over-year to $25000.0; the trailing twelve-month figure through Jun 2025 stood at $25000.0 (down 79.17% YoY), and the FY2024 full-year result was $99000.0, down 13.91% from the prior year.
• Current Leases declined to $25000.0 in Q2 2025 per YARW's latest filing, from $63000.0 in the prior quarter.
• Across five years, Current Leases topped out at $647000.0 in Q1 2021 and bottomed at $25000.0 in Q2 2025.
• Historically, Current Leases has averaged $193615.4 across 5 years, with a median of $117000.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Current Leases sank 92.86% in 2022, then decreased 13.91% in 2024.
• Over 5 years, Current Leases stood at $349000.0 in 2021, then sank by 91.12% to $31000.0 in 2022, then surged by 270.97% to $115000.0 in 2023, then decreased by 13.91% to $99000.0 in 2024, then slumped by 74.75% to $25000.0 in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $25000.0, $63000.0, and $99000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.